$LEXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LEXICON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in LEXICON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,726 | 0 | 27,695 | 18 K to 27.7 K (+54.13 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 17,969 | 15 K to 18 K (+19.96 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 8,837 | 0 | 17,673 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 4,214 | 0 | 4,213 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,270 | 0 | 1,270 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 0 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 2.77 | 3,902 | 10,809 | 55,862 | 59.8 K to 55.9 K (-6.53 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 8,837 | 0 | 59,764 | 50.9 K to 59.8 K (+17.35 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 4,214 | 0 | 50,927 | 46.7 K to 50.9 K (+9.02 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,270 | 0 | 46,713 | 45.4 K to 46.7 K (+2.79 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 45,443 | 43.4 K to 45.4 K (+4.78 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 22,373 | 0 | 44,747 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 8,296 | 0 | 8,297 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,498 | 0 | 2,497 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 4,085 | 0 | 0 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 2.77 | 12,759 | 35,342 | 91,560 | 104.3 K to 91.6 K (-12.23 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 22,373 | 0 | 104,319 | 81.9 K to 104.3 K (+27.30 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 8,296 | 0 | 81,946 | 73.7 K to 81.9 K (+11.26 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,498 | 0 | 73,650 | 71.2 K to 73.7 K (+3.51 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 4,085 | 0 | 71,152 | 67.1 K to 71.2 K (+6.09 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 11,100 | 0 | 22,200 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 5,119 | 0 | 5,118 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 1,518 | 0 | 1,517 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 2,515 | 0 | 0 | |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Payment of Exercise | F | 2.77 | 6,940 | 19,224 | 36,237 | 43.2 K to 36.2 K (-16.07 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 11,100 | 0 | 43,177 | 32.1 K to 43.2 K (+34.60 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 5,119 | 0 | 32,077 | 27 K to 32.1 K (+18.99 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 1,518 | 0 | 26,958 | 25.4 K to 27 K (+5.97 %) |
Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 2,515 | 0 | 25,440 | 22.9 K to 25.4 K (+10.97 %) |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 3.31 | 274,200 | 907,602 | 274,200 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 0.00 | 91,400 | 0 | 91,400 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 3.31 | 209,700 | 694,107 | 209,700 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 0.00 | 69,900 | 0 | 69,900 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 3.31 | 211,690 | 700,694 | 211,690 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 0.00 | 70,560 | 0 | 70,560 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | A | 3.31 | 189,260 | 626,451 | 189,260 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | A | 0.00 | 63,090 | 0 | 63,090 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 3.31 | 247,220 | 818,298 | 247,220 | |
Feb 10 2020 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 0.00 | 82,410 | 0 | 82,410 | |
Sep 19 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.10 | 50,000 | 155,000 | 227,539 | 177.5 K to 227.5 K (+28.16 %) |
Sep 19 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | P | 3.52 | 2,000 | 7,040 | 18,661 | 16.7 K to 18.7 K (+12.00 %) |
Sep 19 2019 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | P | 3.23 | 2,500 | 8,075 | 16,661 | 14.2 K to 16.7 K (+17.65 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 40,290 | 126,108 | 177,539 | 137.2 K to 177.5 K (+29.36 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 40,290 | 126,108 | 177,539 | 137.2 K to 177.5 K (+29.36 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 277 | 867 | 137,249 | 137 K to 137.2 K (+0.20 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 277 | 867 | 137,249 | 137 K to 137.2 K (+0.20 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.12 | 6,333 | 19,759 | 136,972 | 130.6 K to 137 K (+4.85 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.12 | 6,333 | 19,759 | 136,972 | 130.6 K to 137 K (+4.85 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.12 | 3,000 | 9,357 | 130,639 | 127.6 K to 130.6 K (+2.35 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.12 | 3,000 | 9,357 | 130,639 | 127.6 K to 130.6 K (+2.35 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 100 | 313 | 127,639 | 127.5 K to 127.6 K (+0.08 %) |
Sep 18 2019 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 3.13 | 100 | 313 | 127,639 | 127.5 K to 127.6 K (+0.08 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.80 | 3,400 | 9,520 | 313,417 | 310 K to 313.4 K (+1.10 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.79 | 7,500 | 20,925 | 310,017 | 302.5 K to 310 K (+2.48 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.78 | 3,900 | 10,842 | 302,517 | 298.6 K to 302.5 K (+1.31 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.77 | 12,400 | 34,348 | 298,617 | 286.2 K to 298.6 K (+4.33 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.76 | 4,500 | 12,420 | 286,217 | 281.7 K to 286.2 K (+1.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.75 | 6,853 | 18,846 | 281,717 | 274.9 K to 281.7 K (+2.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.74 | 1,900 | 5,206 | 274,864 | 273 K to 274.9 K (+0.70 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.73 | 11,100 | 30,303 | 272,964 | 261.9 K to 273 K (+4.24 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.72 | 8,082 | 21,983 | 261,864 | 253.8 K to 261.9 K (+3.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.71 | 6,443 | 17,461 | 253,782 | 247.3 K to 253.8 K (+2.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.70 | 400 | 1,080 | 247,339 | 246.9 K to 247.3 K (+0.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.69 | 500 | 1,345 | 246,939 | 246.4 K to 246.9 K (+0.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.68 | 1,300 | 3,484 | 246,439 | 245.1 K to 246.4 K (+0.53 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.67 | 4,600 | 12,282 | 245,139 | 240.5 K to 245.1 K (+1.91 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.66 | 1,100 | 2,926 | 240,539 | 239.4 K to 240.5 K (+0.46 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.64 | 2,100 | 5,544 | 239,439 | 237.3 K to 239.4 K (+0.88 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.63 | 4,800 | 12,624 | 237,339 | 232.5 K to 237.3 K (+2.06 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.62 | 3,110 | 8,148 | 232,539 | 229.4 K to 232.5 K (+1.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.61 | 5,795 | 15,125 | 229,429 | 223.6 K to 229.4 K (+2.59 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.60 | 3,990 | 10,374 | 223,634 | 219.6 K to 223.6 K (+1.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.47 | 400 | 988 | 219,644 | 219.2 K to 219.6 K (+0.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 8,869 | 21,818 | 219,244 | 210.4 K to 219.2 K (+4.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.46 | 100 | 246 | 210,375 | 210.3 K to 210.4 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 3,800 | 9,310 | 210,275 | 206.5 K to 210.3 K (+1.84 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.45 | 100 | 245 | 206,475 | 206.4 K to 206.5 K (+0.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 29,880 | 72,907 | 206,375 | 176.5 K to 206.4 K (+16.93 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.44 | 1,700 | 4,140 | 176,495 | 174.8 K to 176.5 K (+0.97 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 18,051 | 43,864 | 174,795 | 156.7 K to 174.8 K (+11.52 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.43 | 900 | 2,183 | 156,744 | 155.8 K to 156.7 K (+0.58 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 15,582 | 37,708 | 155,844 | 140.3 K to 155.8 K (+11.11 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.42 | 200 | 483 | 140,262 | 140.1 K to 140.3 K (+0.14 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.41 | 24,772 | 59,701 | 140,062 | 115.3 K to 140.1 K (+21.49 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 34,087 | 81,809 | 115,290 | 81.2 K to 115.3 K (+41.98 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 152 | 365 | 81,203 | 81.1 K to 81.2 K (+0.19 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.40 | 1,200 | 2,874 | 81,051 | 79.9 K to 81.1 K (+1.50 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.39 | 21,652 | 51,748 | 79,851 | 58.2 K to 79.9 K (+37.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 28,225 | 67,176 | 58,199 | 30 K to 58.2 K (+94.16 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.38 | 400 | 950 | 29,974 | 29.6 K to 30 K (+1.35 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.37 | 5,494 | 13,021 | 29,574 | 24.1 K to 29.6 K (+22.82 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 2,068 | 4,880 | 24,080 | 22 K to 24.1 K (+9.39 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.36 | 200 | 471 | 22,012 | 21.8 K to 22 K (+0.92 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.35 | 1,700 | 3,995 | 21,812 | 20.1 K to 21.8 K (+8.45 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.34 | 1,101 | 2,576 | 20,112 | 19 K to 20.1 K (+5.79 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.33 | 1,300 | 3,029 | 19,011 | 17.7 K to 19 K (+7.34 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.32 | 2,309 | 5,357 | 17,711 | 15.4 K to 17.7 K (+14.99 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.31 | 500 | 1,155 | 15,402 | 14.9 K to 15.4 K (+3.36 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.30 | 800 | 1,840 | 14,902 | 14.1 K to 14.9 K (+5.67 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.29 | 300 | 687 | 14,102 | 13.8 K to 14.1 K (+2.17 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.28 | 300 | 684 | 13,802 | 13.5 K to 13.8 K (+2.22 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.27 | 400 | 908 | 13,502 | 13.1 K to 13.5 K (+3.05 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Buy | P | 2.25 | 200 | 450 | 13,102 | 12.9 K to 13.1 K (+1.55 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.73 | 1,478 | 4,035 | 137,293 | 135.8 K to 137.3 K (+1.09 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.75 | 3,700 | 10,175 | 135,815 | 132.1 K to 135.8 K (+2.80 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.60 | 791 | 2,057 | 132,115 | 131.3 K to 132.1 K (+0.60 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.59 | 200 | 518 | 131,324 | 131.1 K to 131.3 K (+0.15 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.57 | 900 | 2,313 | 131,124 | 130.2 K to 131.1 K (+0.69 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.58 | 100 | 258 | 130,224 | 130.1 K to 130.2 K (+0.08 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.56 | 900 | 2,304 | 130,124 | 129.2 K to 130.1 K (+0.70 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.54 | 800 | 2,032 | 129,224 | 128.4 K to 129.2 K (+0.62 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.55 | 400 | 1,020 | 128,424 | 128 K to 128.4 K (+0.31 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.53 | 820 | 2,075 | 128,024 | 127.2 K to 128 K (+0.64 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.52 | 1,405 | 3,541 | 127,204 | 125.8 K to 127.2 K (+1.12 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.53 | 100 | 253 | 125,799 | 125.7 K to 125.8 K (+0.08 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.54 | 100 | 254 | 125,699 | 125.6 K to 125.7 K (+0.08 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.50 | 1,151 | 2,878 | 125,599 | 124.4 K to 125.6 K (+0.92 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.48 | 3,300 | 8,184 | 124,448 | 121.1 K to 124.4 K (+2.72 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.47 | 2,500 | 6,175 | 121,148 | 118.6 K to 121.1 K (+2.11 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.45 | 200 | 490 | 118,648 | 118.4 K to 118.6 K (+0.17 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.46 | 1,400 | 3,444 | 118,448 | 117 K to 118.4 K (+1.20 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.49 | 1,784 | 4,442 | 117,048 | 115.3 K to 117 K (+1.55 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.49 | 100 | 249 | 115,264 | 115.2 K to 115.3 K (+0.09 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.51 | 776 | 1,948 | 115,164 | 114.4 K to 115.2 K (+0.68 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.52 | 295 | 742 | 114,388 | 114.1 K to 114.4 K (+0.26 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.43 | 500 | 1,215 | 114,093 | 113.6 K to 114.1 K (+0.44 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.41 | 300 | 723 | 113,593 | 113.3 K to 113.6 K (+0.26 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.40 | 800 | 1,920 | 113,293 | 112.5 K to 113.3 K (+0.71 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.38 | 200 | 476 | 112,493 | 112.3 K to 112.5 K (+0.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.48 | 300 | 744 | 112,293 | 112 K to 112.3 K (+0.27 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.48 | 100 | 248 | 111,993 | 111.9 K to 112 K (+0.09 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.47 | 3,336 | 8,240 | 111,893 | 108.6 K to 111.9 K (+3.07 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.47 | 100 | 247 | 108,557 | 108.5 K to 108.6 K (+0.09 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.46 | 5,200 | 12,792 | 108,457 | 103.3 K to 108.5 K (+5.04 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.45 | 2,400 | 5,880 | 103,257 | 100.9 K to 103.3 K (+2.38 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.44 | 15,158 | 36,986 | 100,857 | 85.7 K to 100.9 K (+17.69 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.44 | 400 | 974 | 85,699 | 85.3 K to 85.7 K (+0.47 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.43 | 5,225 | 12,697 | 85,299 | 80.1 K to 85.3 K (+6.53 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.42 | 9,943 | 24,062 | 80,074 | 70.1 K to 80.1 K (+14.18 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.42 | 1,000 | 2,415 | 70,131 | 69.1 K to 70.1 K (+1.45 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.41 | 8,112 | 19,550 | 69,131 | 61 K to 69.1 K (+13.29 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.41 | 200 | 481 | 61,019 | 60.8 K to 61 K (+0.33 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.40 | 9,450 | 22,680 | 60,819 | 51.4 K to 60.8 K (+18.40 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.39 | 14,338 | 34,268 | 51,369 | 37 K to 51.4 K (+38.72 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.39 | 1,396 | 3,329 | 37,031 | 35.6 K to 37 K (+3.92 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.38 | 9,784 | 23,286 | 35,635 | 25.9 K to 35.6 K (+37.85 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.37 | 2,206 | 5,228 | 25,851 | 23.6 K to 25.9 K (+9.33 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.36 | 1,200 | 2,832 | 23,645 | 22.4 K to 23.6 K (+5.35 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.35 | 600 | 1,410 | 22,445 | 21.8 K to 22.4 K (+2.75 %) |
Sep 17 2019 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Buy | P | 2.34 | 3,500 | 8,190 | 21,845 | 18.3 K to 21.8 K (+19.08 %) |